Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

PRCT

Procept BioRobotics Corp

May 03 • 04:00PM ET

64.31

Dollar change +2.57
Percentage change 4.16	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VB BOTZ VXF VBK IWO IHI SCHA VHT

Index	RUT	P/E	-	EPS (ttm)	-2.12	Insider Own	4.70%	Shs Outstand	50.77M	Perf Week	24.08%
Market Cap	3.31B	Forward P/E	-	EPS next Y	-1.50	Insider Trans	-14.56%	Shs Float	48.98M	Perf Month	40.63%
Income	-103.37M	PEG	-	EPS next Q	-0.52	Inst Own	88.44%	Short Float	10.94%	Perf Quarter	34.23%
Sales	156.33M	P/S	21.14	EPS this Y	13.24%	Inst Trans	-6.33%	Short Ratio	9.82	Perf Half Y	133.43%
Book/sh	5.14	P/B	12.52	EPS next Y	22.70%	ROA	-30.98%	Short Interest	5.36M	Perf Year	120.84%
Cash/sh	4.39	P/C	14.65	EPS next 5Y	10.80%	ROE	-47.29%	52W Range	24.83 - 63.26	Perf YTD	53.45%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-23.27%	ROI	-30.07%	52W High	1.66%	Beta	0.95
Dividend TTM	-	Quick Ratio	7.44	Sales past 5Y	142.74%	Gross Margin	50.90%	52W Low	159.00%	ATR (14)	3.11
Dividend Ex-Date	-	Current Ratio	8.52	EPS Y/Y TTM	3.57%	Oper. Margin	-69.37%	RSI (14)	78.41	Volatility	7.53% 5.78%
Employees	626	Debt/Eq	0.31	Sales Y/Y TTM	83.44%	Profit Margin	-66.12%	Recom	1.22	Target Price	66.43
Option/Short	Yes / Yes	LT Debt/Eq	0.30	EPS Q/Q	19.49%	Payout	-	Rel Volume	2.10	Prev Close	61.74
Sales Surprise	7.11%	EPS Surprise	8.16%	Sales Q/Q	82.51%	Earnings	May 01 BMO	Avg Volume	545.38K	Price	64.31
SMA20	22.62%	SMA50	28.78%	SMA200	60.28%	Trades		Volume	1,142,950	Change	4.16%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-11-23	Initiated	Piper Sandler	Overweight	$42
May-31-23	Initiated	William Blair	Outperform
Oct-31-22	Initiated	BTIG Research	Neutral
Oct-25-22	Initiated	Truist	Buy	$58
Sep-02-22	Initiated	Wells Fargo	Overweight	$49
Jul-15-22	Initiated	KeyBanc Capital Markets	Overweight	$47
Jun-23-22	Initiated	B. Riley Securities	Buy	$53
Oct-11-21	Initiated	SVB Leerink	Outperform	$46
Oct-11-21	Initiated	Guggenheim	Buy	$45
Oct-11-21	Initiated	Goldman	Neutral	$37
Oct-11-21	Initiated	Cowen	Outperform	$50
Oct-11-21	Initiated	BofA Securities	Buy	$48

Show Previous Ratings

May-04-24 02:58AM	Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
May-03-24 04:00PM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 08:15AM	Truist Raises PROCEPT BioRobotics' PT to $72 From $63 After 'Solid' Q1 Beat, Keeps Buy Rating (MT Newswires)
May-01-24 03:59PM	Biotech Leader Procept BioRobotics Surges Past Buy Point On Earnings (Investor's Business Daily) +14.40%
01:53PM	PRCT Stock Earnings: PROCEPT BioRobotics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
12:13PM	Loading…
12:13PM	Procept BioRobotics Shares Rise After Q1 Loss Narrows, Revenue Increases; 2024 Revenue Guidance Revised (MT Newswires)
08:25AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (GlobeNewswire)
Apr-29-24 08:00AM	Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia (GlobeNewswire)
Apr-23-24 08:00AM	PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting (GlobeNewswire) +5.00%
Apr-04-24 04:04PM	PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas (GlobeNewswire)
Apr-02-24 04:03PM	PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024 (GlobeNewswire)
Mar-20-24 07:01PM	PROCEPT BioRobotics Corp (PRCT) President and CEO Reza Zadno Sells Company Shares (GuruFocus.com)
Mar-08-24 01:30AM	EVP, CLO, Corporate Secretary Alaleh Nouri Sells Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Mar-06-24 11:55PM	Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
12:00PM	Loading…
Feb-28-24 12:00PM	Q4 2023 Procept Biorobotics Corp Earnings Call (Thomson Reuters StreetEvents)
10:00AM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 04:02PM	PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Feb-20-24 10:00AM	PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-12-24 04:05PM	PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston (GlobeNewswire)
Feb-10-24 02:07AM	EVP, CLO, CORP. SEC. Alaleh Nouri Sells 20,000 Shares of PROCEPT BioRobotics Corp (GuruFocus.com)
Feb-08-24 05:30PM	CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of Directors (GlobeNewswire)
Jan-11-24 11:02PM	EVP, CLO, CORP. SEC. Alaleh Nouri Sells 16,000 Shares of PROCEPT BioRobotics Corp (GuruFocus.com)
Jan-10-24 03:51AM	Strength Seen in PROCEPT BioRobotics Corporation (PRCT): Can Its 15.1% Jump Turn into More Strength? (Zacks)
Jan-08-24 05:00PM	PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million (GlobeNewswire)
Dec-16-23 07:02AM	Insider Sell Alert: EVP Alaleh Nouri Divests 15,000 Shares of PROCEPT BioRobotics Corp (GuruFocus.com)
Dec-10-23 01:15AM	Insider Sell Alert: Director Frederic Moll Sells 79,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Dec-09-23 01:05AM	EVP, CFO Kevin Waters Sells 15,085 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Dec-05-23 02:44PM	PROCEPT BioRobotics Stock Scores Rising Relative Strength (Investor's Business Daily)
Nov-15-23 01:03AM	Insider Sell Alert: Director Morgan Wood Sells 25,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
04:03PM	Loading…
Nov-13-23 04:03PM	PROCEPT BioRobotics to Present at the 35 Annual Piper Sandler Healthcare Conference in New York City (GlobeNewswire)
Nov-06-23 09:55AM	Wall Street Analysts Predict a 25.54% Upside in PROCEPT BioRobotics Corporation (PRCT): Here's What You Should Know (Zacks)
Nov-02-23 04:07PM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2023 Earnings Call Transcript (Insider Monkey) +18.37%
09:33AM	Q3 2023 PROCEPT BioRobotics Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 04:02PM	PROCEPT BioRobotics Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance (GlobeNewswire)
Oct-25-23 10:02AM	PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-16-23 04:05PM	PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023 (GlobeNewswire) +9.58%
10:23AM	Wayfair upgraded, JD.com downgraded: Wall Street's top analyst calls (The Fly)
08:43AM	Tandem Diabetes Care, Inc. (TNDM) Soars 6.0%: Is Further Upside Left in the Stock? (Zacks)
Oct-12-23 08:00AM	The National Institute for Health and Care Excellence Endorses Aquablation Therapy with 'Standard Arrangements' Recommendation (GlobeNewswire)
Sep-20-23 08:00AM	PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose (GlobeNewswire)
Sep-12-23 08:00AM	PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer (GlobeNewswire)
Aug-22-23 08:00AM	PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan (GlobeNewswire)
Aug-17-23 04:05PM	PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston (GlobeNewswire)
Aug-16-23 08:00AM	NorthShore University HealthSystem offers expanded access to treat most common prostate ailment (GlobeNewswire)
Aug-11-23 09:36AM	Twilio upgraded, Sealed Air downgraded: Wall Street's top analyst calls (The Fly)
Aug-02-23 07:14AM	The one-year earnings decline has likely contributed toPROCEPT BioRobotics' (NASDAQ:PRCT) shareholders losses of 14% over that period (Simply Wall St.) +6.13%
Aug-01-23 10:10PM	PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock (GlobeNewswire)
04:06PM	PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock (GlobeNewswire)
Jul-27-23 08:35AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -7.14%
07:00AM	PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance (GlobeNewswire)
Jul-11-23 04:03PM	PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023 (GlobeNewswire) -6.42%
May-17-23 06:12AM	Positive week for PROCEPT BioRobotics Corporation (NASDAQ:PRCT) institutional investors who lost 17% over the past year (Simply Wall St.)
May-14-23 02:57PM	7 Growth Stocks That Could Double Your Money in 2023 (InvestorPlace)
Apr-28-23 08:00AM	Five-Year Data from the WATER II Study Demonstrate Aquablation Therapy Delivers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms while Preserving Sexual Function in Men with Large Prostates (GlobeNewswire) +13.82%
Apr-27-23 12:52PM	Why Shares of Procept Biorobotics Were Slumping Thursday (Motley Fool) -25.31%
08:25AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance (GlobeNewswire)
Apr-24-23 10:00AM	TransMedics (TMDX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-20-23 10:03AM	Analysts Estimate PROCEPT BioRobotics Corporation (PRCT) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-06-23 06:33AM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Shares Could Be 49% Below Their Intrinsic Value Estimate (Simply Wall St.)
Apr-05-23 04:03PM	PROCEPT BioRobotics to Report First Quarter 2023 Financial Results on April 27, 2023 and Present at the Bank of America 2023 Health Care Conference in Las Vegas (GlobeNewswire)
Apr-03-23 08:00AM	PROCEPT BioRobotics Corp. Announces United Healthcare Coverage of Aquablation Therapy for Men with Enlarged Prostates (GlobeNewswire) +11.48%
Mar-30-23 04:05PM	PROCEPT BioRobotics Corp. Announces Investor Event at 2023 AUA Annual Meeting in Chicago (GlobeNewswire)
Mar-27-23 08:08AM	Intuitive Surgical, Inc. (ISRG) Stock Jumps 4.9%: Will It Continue to Soar? (Zacks)
Mar-07-23 07:00AM	Aquablation Therapy is the first surgical robotics system to receive a MedTech Innovation Briefing (MIB) from the National Institute for Health Care Excellence (GlobeNewswire)
Mar-02-23 04:05PM	PROCEPT BioRobotics Corp. to Present at the Virtual Key Bank Life Sciences & MedTech Investor Forum (GlobeNewswire) -8.48%
Mar-01-23 09:52AM	Q4 2022 PROCEPT BioRobotics Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-28-23 05:25PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:03PM	PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2022 Results (GlobeNewswire)
Feb-22-23 05:33AM	PROCEPT BioRobotics' (NASDAQ:PRCT) investors will be pleased with their favorable 68% return over the last year (Simply Wall St.)
Feb-16-23 09:15AM	Integer (ITGR) Beats Q4 Earnings and Revenue Estimates (Zacks)
Feb-13-23 04:02PM	PROCEPT BioRobotics Corp. to Present at the 43rd Annual Cowen Health Care Conference in Boston (GlobeNewswire)
Jan-09-23 08:00AM	PROCEPT BioRobotics Announces Preliminary Fourth Quarter and Fiscal Year 2022 Revenue (GlobeNewswire) -6.23%
Dec-14-22 04:05PM	PROCEPT BioRobotics Corp. to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.19%
Dec-12-22 03:44PM	12 Best Small-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Nov-09-22 07:32AM	PROCEPT BioRobotics Third Quarter 2022 Earnings: US$0.51 loss per share (vs US$1.22 loss in 3Q 2021) (Simply Wall St.)
Nov-03-22 05:55PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:03PM	PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance (GlobeNewswire)
Oct-27-22 10:02AM	PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
07:37AM	Is PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Trading At A 28% Discount? (Simply Wall St.)
Oct-12-22 08:00AM	PROCEPT BioRobotics to Report Third Quarter 2022 Financial Results on November 3, 2022 (GlobeNewswire)
Oct-10-22 08:00AM	PROCEPT BioRobotics Announces $52 Million Debt Refinancing (GlobeNewswire)
Oct-04-22 10:15AM	The Zacks Analyst Blog Highlights TransMedics, PROCEPT BioRobotics and Sensus Healthcare (Zacks)
Oct-03-22 09:16AM	3 Resilient Medical Stocks to Watch as Rate Hikes Continue (Zacks)
Sep-19-22 08:00AM	Providence Advances Surgical Robotics Program with Multi-System, National Contract for PROCEPT BioRobotics AquaBeam Systems (GlobeNewswire)
Sep-15-22 06:15AM	PROCEPT BioRobotics (NASDAQ:PRCT) rallies 4.3% this week, taking one-year gains to 12% (Simply Wall St.)
Aug-22-22 04:03PM	PROCEPT BioRobotics Corp. to Present at 2022 Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-05-22 05:30PM	PROCEPT BioRobotics Corporation (PRCT) Q2 2022 Earnings Call Transcript (Motley Fool) +9.56%
Aug-04-22 04:03PM	PROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance (GlobeNewswire)
Jul-14-22 04:02PM	PROCEPT BioRobotics to Report Second Quarter 2022 Financial Results on August 4, 2022 (GlobeNewswire)
Jul-10-22 08:32AM	Insiders of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) received good value on their investment after their US$11m purchase jumped US$3.3m in value (Simply Wall St.)
Jun-16-22 02:30PM	Procept Biorobotics Corp Joins Elite Club Of Stocks With RS Ratings Over 90 (Investor's Business Daily)
Jun-09-22 09:01AM	How Much Of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Do Insiders Own? (Simply Wall St.)
08:00AM	PROCEPT BioRobotics Corporation Announces Additional Positive Coverage Policies Regarding Aquablation Therapy for Men with Enlarged Prostates (GlobeNewswire)
May-10-22 06:20AM	Need To Know: Analysts Are Much More Bullish On PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Revenues (Simply Wall St.)
May-05-22 04:02PM	PROCEPT BioRobotics Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance (GlobeNewswire) -5.59%
Apr-28-22 08:00AM	PROCEPT BioRobotics Corporation Announces Aetna and Independence Blue Cross Blue Shield Positive Coverage Decisions Regarding Aquablation Therapy for Men with Enlarged Prostates (GlobeNewswire) +5.81%
Apr-12-22 04:02PM	PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare Conference on May 11, 2022 (GlobeNewswire)
Apr-11-22 08:00AM	PROCEPT BioRobotics Corp. Announces Investor Event at 2022 AUA Annual Meeting in New Orleans (GlobeNewswire)

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nouri Alaleh	EVP, CLO, CORP. SEC.	May 03 '24	Option Exercise	6.87	30,432	208,978	92,904	May 03 09:40 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	May 03 '24	Sale	62.97	30,432	1,916,428	62,472	May 03 09:40 PM
Krummel Thomas M	Director	May 01 '24	Sale	60.00	20,000	1,200,000	45,631	May 03 09:41 PM
Zadno Reza	President, CEO	Mar 18 '24	Sale	48.83	5,391	263,243	241,319	Mar 20 04:46 PM
Waters Kevin	EVP, CFO	Mar 18 '24	Sale	48.83	1,024	50,002	102,149	Mar 20 04:48 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 18 '24	Sale	48.83	441	21,534	62,472	Mar 20 04:52 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Mar 18 '24	Sale	48.83	244	11,915	55,860	Mar 20 04:41 PM
Waters Kevin	EVP, CFO	Mar 15 '24	Option Exercise	4.53	53,757	243,692	103,173	Mar 18 06:05 PM
Zadno Reza	President, CEO	Mar 06 '24	Sale	46.67	9,179	428,384	246,710	Mar 07 07:50 PM
Waters Kevin	EVP, CFO	Mar 06 '24	Sale	46.67	3,435	160,311	49,416	Mar 07 07:51 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 06 '24	Sale	46.67	2,749	128,296	62,913	Mar 07 07:53 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Mar 06 '24	Sale	46.67	1,759	82,093	56,104	Mar 07 07:50 PM
Krummel Thomas M	Director	Mar 04 '24	Sale	48.53	20,000	970,643	65,631	Mar 06 04:50 PM
Waters Kevin	EVP, CFO	Feb 12 '24	Option Exercise	4.52	22,349	101,017	55,872	Feb 13 04:37 PM
Waters Kevin	EVP, CFO	Feb 12 '24	Sale	50.16	22,349	1,121,062	33,523	Feb 13 04:37 PM
Waters Kevin	EVP, CFO	Feb 09 '24	Option Exercise	4.52	28,677	129,620	62,200	Feb 09 05:09 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Feb 09 '24	Option Exercise	5.18	14,694	76,115	62,045	Feb 09 05:02 PM
Waters Kevin	EVP, CFO	Feb 09 '24	Sale	50.09	28,677	1,436,379	33,523	Feb 09 05:09 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Feb 09 '24	Sale	49.97	14,694	734,314	47,351	Feb 09 05:02 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Feb 07 '24	Option Exercise	5.18	5,306	27,485	52,657	Feb 09 05:02 PM
Waters Kevin	EVP, CFO	Feb 07 '24	Option Exercise	4.52	904	4,086	34,427	Feb 09 05:09 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Feb 07 '24	Sale	49.95	5,306	265,053	47,351	Feb 09 05:02 PM
Waters Kevin	EVP, CFO	Feb 07 '24	Sale	50.00	904	45,200	33,523	Feb 09 05:09 PM
Waters Kevin	EVP, CFO	Jan 09 '24	Option Exercise	4.52	17,310	78,241	50,833	Jan 11 05:03 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Jan 09 '24	Option Exercise	4.56	16,000	72,960	63,351	Jan 11 05:12 PM
Waters Kevin	EVP, CFO	Jan 09 '24	Sale	45.07	17,310	780,247	33,523	Jan 11 05:03 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Jan 09 '24	Sale	44.97	16,000	719,475	47,351	Jan 11 05:12 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 15 '23	Option Exercise	4.56	11,796	53,790	58,729	Dec 15 06:28 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 15 '23	Sale	42.97	11,796	506,843	46,933	Dec 15 06:28 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 14 '23	Option Exercise	4.56	3,204	14,610	50,137	Dec 15 06:28 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 14 '23	Sale	42.95	3,204	137,618	46,933	Dec 15 06:28 PM
Waters Kevin	EVP, CFO	Dec 13 '23	Option Exercise	4.52	71,465	323,022	104,988	Dec 15 06:19 PM
Waters Kevin	EVP, CFO	Dec 13 '23	Sale	40.05	71,465	2,862,216	33,523	Dec 15 06:19 PM
Waters Kevin	EVP, CFO	Dec 08 '23	Option Exercise	4.52	6,888	31,134	48,608	Dec 08 05:58 PM
Waters Kevin	EVP, CFO	Dec 08 '23	Sale	40.02	6,888	275,640	33,523	Dec 08 05:58 PM
Waters Kevin	EVP, CFO	Dec 07 '23	Option Exercise	4.52	3,837	17,343	41,720	Dec 08 05:58 PM
Waters Kevin	EVP, CFO	Dec 07 '23	Sale	40.00	3,837	153,480	40,411	Dec 08 05:58 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 06 '23	Option Exercise	4.52	6,096	27,554	53,029	Dec 08 08:05 PM
Waters Kevin	EVP, CFO	Dec 06 '23	Option Exercise	4.52	4,360	19,707	37,883	Dec 08 05:58 PM
MOLL FREDERIC H	Director	Dec 06 '23	Sale	38.75	79,000	3,061,355	808,233	Dec 08 05:33 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 06 '23	Sale	39.96	6,096	243,572	46,933	Dec 08 08:05 PM
Waters Kevin	EVP, CFO	Dec 06 '23	Sale	40.02	4,360	174,493	44,248	Dec 08 05:58 PM
Wood Morgan Colby	Director	Nov 13 '23	Sale	32.19	25,000	804,810	112,425	Nov 14 04:12 PM
Zadno Reza	President, CEO	Oct 18 '23	Option Exercise	4.37	5,148	22,497	200,956	Oct 18 04:28 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Jul 27 '23	Option Exercise	4.52	7,903	35,722	54,836	Jul 31 04:05 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Jul 27 '23	Sale	40.00	7,903	316,129	46,933	Jul 31 04:05 PM
Waters Kevin	EVP, CFO	Jun 15 '23	Sale	35.12	22,631	794,912	33,523	Jun 15 05:09 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	May 08 '23	Option Exercise	4.52	12,123	54,796	46,933	May 10 04:41 PM

Open in Screener

EW

Edwards Lifesciences Corp

May 03 • 04:00PM ET

85.25

Dollar change +0.19
Percentage change 0.22	%

Healthcare • Medical Devices • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

EW Edwards Lifesciences Corp daily Stock Chart

Held by: VTI VOO VUG IVV IHI VHT IWF QUAL RSP VV

Index	S&P 500	P/E	36.64	EPS (ttm)	2.33	Insider Own	1.58%	Shs Outstand	601.10M	Perf Week	-1.37%
Market Cap	51.37B	Forward P/E	27.38	EPS next Y	3.11	Insider Trans	-4.63%	Shs Float	593.08M	Perf Month	-6.52%
Income	1.41B	PEG	3.91	EPS next Q	0.70	Inst Own	82.51%	Short Float	1.24%	Perf Quarter	-0.98%
Sales	6.14B	P/S	8.36	EPS this Y	10.39%	Inst Trans	-0.08%	Short Ratio	1.96	Perf Half Y	33.56%
Book/sh	11.82	P/B	7.21	EPS next Y	12.38%	ROA	15.38%	Short Interest	7.38M	Perf Year	-3.23%
Cash/sh	2.82	P/C	30.20	EPS next 5Y	9.36%	ROE	21.59%	52W Range	60.57 - 96.12	Perf YTD	11.80%
Dividend Est.	-	P/FCF	189.28	EPS past 5Y	15.35%	ROI	18.14%	52W High	-11.31%	Beta	1.12
Dividend TTM	-	Quick Ratio	2.67	Sales past 5Y	10.28%	Gross Margin	76.11%	52W Low	40.75%	ATR (14)	2.07
Dividend Ex-Date	-	Current Ratio	3.75	EPS Y/Y TTM	-3.43%	Oper. Margin	27.71%	RSI (14)	38.07	Volatility	2.30% 2.25%
Employees	19800	Debt/Eq	0.10	Sales Y/Y TTM	11.68%	Profit Margin	23.01%	Recom	2.12	Target Price	95.95
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	4.50%	Payout	0.00%	Rel Volume	0.61	Prev Close	85.06
Sales Surprise	1.80%	EPS Surprise	2.66%	Sales Q/Q	9.50%	Earnings	Apr 25 AMC	Avg Volume	3.76M	Price	85.25
SMA20	-3.56%	SMA50	-5.25%	SMA200	8.60%	Trades		Volume	2,294,544	Change	0.22%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-07-24	Upgrade	BofA Securities	Neutral → Buy
Feb-02-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$94
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$80 → $77
Dec-11-23	Downgrade	Citigroup	Buy → Neutral
Nov-28-23	Downgrade	Wolfe Research	Peer Perform → Underperform	$57
Sep-26-23	Upgrade	Oppenheimer	Perform → Outperform	$90
Jul-19-23	Initiated	Robert W. Baird	Outperform	$107
May-30-23	Resumed	Morgan Stanley	Overweight	$102
Mar-29-23	Initiated	UBS	Neutral	$84
Mar-08-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$97 → $78
Feb-06-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-31-23	Downgrade	Bernstein	Outperform → Underperform	$95 → $66
Jan-30-23	Downgrade	Piper Sandler	Overweight → Neutral	$95 → $80
Dec-06-22	Downgrade	Stifel	Buy → Hold	$95 → $75
Oct-28-22	Downgrade	Oppenheimer	Outperform → Perform
Oct-26-22	Initiated	Mizuho	Buy	$100
Oct-18-22	Initiated	Barclays	Overweight	$96
Oct-12-22	Initiated	Jefferies	Buy	$110
Jul-29-22	Downgrade	Canaccord Genuity	Buy → Hold	$115 → $106
Apr-13-22	Initiated	Truist	Buy	$145

Show Previous Ratings

May-01-24 05:27PM	Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing (MT Newswires)
09:40AM	Is Edwards Lifesciences (EW) Outperforming Other Medical Stocks This Year? (Zacks)
09:35AM	Down -10.22% in 4 Weeks, Here's Why You Should You Buy the Dip in Edwards Lifesciences (EW) (Zacks)
Apr-30-24 05:03PM	Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing (MT Newswires)
10:20AM	Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:22PM	Loading…
Apr-29-24 02:22PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
12:18PM	Investing in Edwards Lifesciences (EW)? Don't Miss Assessing Its International Revenue Trends (Zacks)
07:23AM	Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72 (MT Newswires)
Apr-26-24 04:09PM	This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss (Investor's Business Daily)
11:21AM	Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92 (MT Newswires)
11:09AM	Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up (Zacks)
10:54AM	Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83 (MT Newswires)
10:42AM	UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating (MT Newswires)
10:38AM	Q1 2024 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
10:29AM	Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85 (MT Newswires)
09:53AM	Loading…
09:53AM	Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86 (MT Newswires)
08:28AM	Edwards gets Q1 boost as Pascal valve repair sales ramp up (MedTech Dive)
03:40AM	Edwards Lifesciences Corp (EW) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
Apr-25-24 06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics (Zacks)
05:52PM	Edwards Lifesciences Q1 Earnings: Mixed Results with Adjusted EPS Beating Estimates (GuruFocus.com)
05:30PM	Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates (Zacks)
05:04PM	Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff (Investor's Business Daily)
04:34PM	Edwards Lifesciences Q1 Adjusted Earnings, Net Sales Increase, Q2 Guidance Set (MT Newswires)
04:26PM	Edwards Lifesciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences Reports First Quarter Results (Business Wire)
Apr-23-24 06:14AM	Boston Scientific, Dexcom and Edwards next as earnings season rolls on (MedTech Dive)
Apr-22-24 09:16AM	Unveiling Edwards Lifesciences (EW) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Apr-19-24 01:08AM	Spinoffs, sales and tuck-ins top medtech deal priorities: Moodys (MedTech Dive)
Apr-18-24 10:01AM	Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
07:10AM	Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024 (Business Wire)
11:01AM	Loading…
Apr-17-24 11:01AM	Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings? (Zacks)
Apr-12-24 04:37AM	Abbotts Nadim Geloo on Triclips US launch, Edwards competition (MedTech Dive)
Apr-07-24 04:30PM	Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It (Business Wire)
Mar-26-24 08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
Mar-25-24 09:40AM	Are Medical Stocks Lagging Edwards Lifesciences (EW) This Year? (Zacks)
Mar-19-24 02:24PM	Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark (Investor's Business Daily)
01:38PM	Edwards Lifesciences (EW) Up 21.8% YTD: What's Driving It? (Zacks)
Mar-15-24 04:02PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
10:50AM	Edwards Lifesciences (EW) Hits 52-Week High: What's Driving It? (Zacks)
Mar-13-24 11:57AM	Edwards Lifesciences' (EW) SAPIEN TAVR Study Outcome Favorable (Zacks)
Mar-11-24 02:00PM	Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR (Business Wire)
Mar-07-24 04:57PM	S&P 500 Gains and Losses Today: Index Notches Record Close Ahead of Jobs Report (Investopedia) +6.20%
11:31AM	Edwards Lifesciences (EW) Up 2% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-06-24 09:43AM	Edwards (EW) Gains From RESILIA's Global Adoption, TAVR Growth (Zacks)
Feb-26-24 11:54AM	Here's Why You Should Buy Edward Lifesciences (EW) Stock Now (Zacks)
Feb-23-24 07:05AM	Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference (Business Wire)
Feb-18-24 01:26PM	25 Most Valuable Medical Device Companies in the US (Insider Monkey)
Feb-15-24 09:36AM	Edwards (EW) Gains From Balanced Core Growth and New Launches (Zacks)
Feb-13-24 12:09AM	Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight (GuruFocus.com)
Feb-09-24 02:21AM	Edwards Lifesciences Corp Director Heisz Stone Sells 7,056 Shares (GuruFocus.com)
Feb-07-24 04:11PM	Edwards Lifesciences' Fortunes Are Reaccelerating, Analyst Says But Its Stock Isn't (Investor's Business Daily)
11:19AM	Edwards Lifesciences Corporation (NYSE:EW) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:31AM	Edwards Lifesciences (EW) Q4 Earnings Meet, Margins Dip (Zacks)
09:06AM	Q4 2023 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
05:54AM	How Edwards Evoque valve won an early nod from the FDA (MedTech Dive)
Feb-06-24 07:55PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics (Zacks)
05:25PM	Edwards Lifesciences (EW) Q4 Earnings Match Estimates (Zacks)
04:54PM	Edwards Lifesciences Corp (EW) Reports Robust Q4 and Full-Year 2023 Financial Results (GuruFocus.com)
04:44PM	Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat (Investor's Business Daily)
04:40PM	Edwards Lifesciences: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences Reports Fourth Quarter Results (Business Wire)
07:18AM	Edwards Lifesciences (EW) Wins FDA Nod for the EVOQUE System (Zacks)
Feb-02-24 07:00AM	Edwards EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve (Business Wire) +9.38%
06:27AM	Edwards receives FDA approval for first transcatheter tricuspid valve replacement treatment (MedTech Dive)
Feb-01-24 09:15AM	Stay Ahead of the Game With Edwards Lifesciences (EW) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
07:44AM	Strength Seen in Edwards Lifesciences (EW): Can Its 6.2% Jump Turn into More Strength? (Zacks)
Jan-30-24 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024 (Business Wire)
06:15AM	4 heart device trends shaping the medtech sector in 2024 (MedTech Dive)
Jan-23-24 07:07AM	Edwards risks TAVR market share slip amid challenges from Abbott, Boston Scientific: survey (MedTech Dive)
Jan-19-24 11:26AM	What's in Store for Edwards Lifesciences (EW) in Q4 Earnings? (Zacks)
Jan-16-24 01:20AM	Edwards Lifesciences Corporation (EW) Fell in Q4 Despite Double-Digit Revenue Growth (Insider Monkey)
Jan-03-24 07:40AM	Here's Why You Should Retain Edward Lifesciences (EW) Stock Now (Zacks)
Jan-02-24 09:00AM	Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-20-23 05:24AM	Fears Of Negative Clinical Trial Result Dragged Edwards Lifesciences Corporation (EW) in Q3 (Insider Monkey)
Dec-14-23 07:49PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
Dec-11-23 12:27PM	Edwards Lifesciences (EW) Forwards Growth Strategy and Outlook (Zacks)
Dec-08-23 05:11AM	Edwards to spin off its critical care business (MedTech Dive)
Dec-07-23 05:00PM	S&P 500 Gains and Losses Today: AI Excitement Powers AMD, Alphabet (Investopedia)
08:30AM	Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference (Business Wire)
Nov-26-23 05:56AM	12 Best Medical Technology Stocks To Buy Now (Insider Monkey)
Nov-25-23 06:58AM	Could Ozempic Harm These 3 Medical Device Stocks? (Motley Fool)
Nov-24-23 11:31AM	Edwards Lifesciences (EW) Up 6.8% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-23-23 06:06AM	Here's Why You Should Retain Edward Lifesciences (EW) Stock Now (Zacks)
Oct-30-23 11:40AM	ITGR or EW: Which Is the Better Value Stock Right Now? (Zacks)
Oct-27-23 07:30AM	DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook (Zacks)
Oct-26-23 06:15PM	Why Edwards Lifesciences Stock Plummeted Today (Motley Fool) -8.14%
03:06PM	CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION (PR Newswire)
02:00PM	TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION (PR Newswire)
11:33AM	Edwards Lifesciences Corporation (NYSE:EW) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:17AM	Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip (Zacks)
11:12AM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
10:08AM	CONMED (CNMD) Beats on Q3 Earnings, Ups '23 EPS View (Zacks)
07:23AM	Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks)
07:20AM	Q3 2023 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-25-23 06:00PM	Edwards Lifesciences Corp (EW) Reports Q3 Earnings: Sales Growth and New Therapy Approvals (GuruFocus.com)
06:00PM	Edwards Lifesciences (EW) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:40PM	Edwards Lifesciences (EW) Q3 Earnings Match Estimates (Zacks)
04:32PM	Edwards Lifesciences: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences quarterly sales jump on robust demand for heart devices (Reuters)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MUSSALLEM MICHAEL A	Director	May 02 '24	Option Exercise	36.75	29,350	1,078,612	33,836	May 02 06:05 PM
MUSSALLEM MICHAEL A	Director	May 02 '24	Sale	84.77	29,350	2,487,966	4,486	May 02 06:05 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Option Exercise	36.75	14,400	529,200	188,249	May 01 05:17 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Sale	84.21	14,400	1,212,687	173,849	May 01 05:17 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Option Exercise	36.75	7,250	266,438	26,324	Apr 30 04:56 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Sale	85.80	7,250	622,062	19,074	Apr 30 04:56 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Option Exercise	36.75	857	31,495	18,345	Apr 09 05:33 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Sale	92.34	857	79,135	17,488	Apr 09 05:33 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Option Exercise	36.75	14,400	529,200	188,249	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Option Exercise	36.75	12,500	459,375	52,268	Apr 08 05:10 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Sale	92.32	14,400	1,329,472	173,849	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Sale	92.33	12,500	1,154,142	39,768	Apr 08 05:10 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Apr 04 06:26 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Sale	92.42	29,350	2,712,418	4,486	Apr 04 06:26 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Option Exercise	36.75	7,255	266,621	26,329	Apr 01 06:55 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Sale	94.89	7,255	688,423	19,074	Apr 01 06:55 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Option Exercise	36.75	14,500	532,875	54,003	Mar 13 05:44 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Sale	91.01	14,500	1,319,696	39,503	Mar 13 05:44 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Option Exercise	36.75	14,400	529,200	187,984	Mar 11 06:00 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Sale	91.68	14,400	1,320,149	173,584	Mar 11 06:00 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Option Exercise	36.75	1,715	63,026	18,928	Mar 07 06:22 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Sale	90.98	1,715	156,031	17,213	Mar 07 06:22 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Mar 04 07:16 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Sale	86.67	29,350	2,543,737	4,486	Mar 04 07:16 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Option Exercise	36.75	7,255	266,621	26,329	Feb 29 05:12 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Sale	85.59	7,255	620,923	19,074	Feb 29 05:12 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Option Exercise	36.86	7,056	260,107	10,757	Feb 26 05:52 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Sale	87.61	3,058	267,911	67,219	Feb 26 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Option Exercise	59.26	7,000	414,797	30,950	Feb 21 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Sale	86.74	8,200	711,272	22,750	Feb 21 05:52 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Option Exercise	36.75	27,000	992,250	61,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Sale	85.62	27,000	2,311,654	34,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Option Exercise	36.75	20,000	735,000	54,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Option Exercise	36.75	11,000	404,250	50,503	Feb 13 04:51 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Sale	86.46	20,000	1,729,200	34,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Sale	85.83	11,000	944,155	39,503	Feb 13 04:51 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Option Exercise	36.75	12,210	448,718	25,297	Feb 12 05:44 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Sale	87.00	12,210	1,062,270	13,087	Feb 12 05:44 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Option Exercise	36.86	7,056	260,107	34,036	Feb 08 06:08 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Sale	86.45	7,056	609,991	26,980	Feb 08 06:08 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Feb 05 06:37 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Sale	87.49	29,350	2,567,754	4,486	Feb 05 06:37 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Option Exercise	36.75	7,255	266,621	26,503	Feb 01 05:52 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Sale	78.29	7,255	567,994	19,248	Feb 01 05:52 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Option Exercise	36.75	10,000	367,500	49,503	Jan 12 05:36 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Sale	75.67	10,000	756,700	39,503	Jan 12 05:36 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Jan 05 07:19 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Sale	72.98	29,350	2,142,089	4,486	Jan 05 07:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Option Exercise	36.75	14,510	533,242	33,758	Dec 29 04:25 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Sale	76.55	14,510	1,110,794	19,248	Dec 29 04:25 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Option Exercise	59.26	7,000	414,797	30,950	Dec 15 05:22 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Sale	78.25	7,000	547,724	23,950	Dec 15 05:22 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Option Exercise	45.28	8,658	392,006	222,452	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Option Exercise	36.75	8,000	294,000	47,503	Dec 13 07:04 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Sale	74.62	29,350	2,190,043	4,486	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Sale	71.86	8,658	622,164	213,794	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Sale	71.86	8,000	574,880	39,503	Dec 13 07:04 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Option Exercise	59.26	3,500	207,398	27,450	Dec 06 05:01 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Sale	70.00	3,500	245,006	23,950	Dec 06 05:01 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Option Exercise	36.75	6,000	220,500	45,503	Nov 13 05:21 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Sale	65.30	8,660	565,460	213,794	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Sale	65.30	6,000	391,780	39,503	Nov 13 05:21 PM
MUSSALLEM MICHAEL A	Director	Nov 03 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Nov 06 06:33 PM
MUSSALLEM MICHAEL A	Director	Nov 03 '23	Sale	67.18	29,350	1,971,733	4,486	Nov 06 06:33 PM
Ullem Scott B.	CVP, Chief Financial Officer	Oct 31 '23	Option Exercise	36.75	7,255	266,621	26,503	Oct 31 05:22 PM
Ullem Scott B.	CVP, Chief Financial Officer	Oct 31 '23	Sale	62.66	7,255	454,569	19,248	Oct 31 05:22 PM
Wood Larry L	Global President TAVR & Surg	Oct 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Oct 13 05:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 13 '23	Option Exercise	36.75	5,000	183,750	44,503	Oct 13 05:01 PM
Wood Larry L	Global President TAVR & Surg	Oct 13 '23	Sale	70.00	8,660	606,198	213,794	Oct 13 05:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 13 '23	Sale	69.98	5,000	349,909	39,503	Oct 13 05:01 PM
Szyman Catherine M.	CVP, Critical Care	Oct 10 '23	Option Exercise	36.75	5,000	183,750	39,814	Oct 10 06:23 PM
Szyman Catherine M.	CVP, Critical Care	Oct 10 '23	Sale	72.68	5,000	363,400	34,814	Oct 10 06:23 PM
Chopra Daveen	CVP, TMTT	Oct 03 '23	Option Exercise	59.26	8,500	503,682	32,450	Oct 03 04:58 PM
Chopra Daveen	CVP, TMTT	Oct 03 '23	Sale	70.00	8,500	595,000	23,950	Oct 03 04:58 PM
MUSSALLEM MICHAEL A	Director	Oct 02 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Oct 02 06:51 PM
MUSSALLEM MICHAEL A	Director	Oct 02 '23	Sale	68.84	29,350	2,020,454	4,486	Oct 02 06:51 PM
Ullem Scott B.	CVP, Chief Financial Officer	Sep 29 '23	Option Exercise	36.75	7,255	266,621	26,503	Sep 29 04:49 PM
Ullem Scott B.	CVP, Chief Financial Officer	Sep 29 '23	Sale	69.54	7,255	504,527	19,248	Sep 29 04:49 PM
Wood Larry L	Global President TAVR & Surg	Sep 14 '23	Option Exercise	45.28	8,660	392,096	222,454	Sep 14 08:00 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 14 '23	Option Exercise	36.75	4,500	165,375	44,003	Sep 14 08:00 PM
Wood Larry L	Global President TAVR & Surg	Sep 14 '23	Sale	73.63	8,660	637,615	213,794	Sep 14 08:00 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 14 '23	Sale	73.71	4,500	331,695	39,503	Sep 14 08:00 PM
Szyman Catherine M.	CVP, Critical Care	Sep 08 '23	Option Exercise	36.75	5,000	183,750	39,814	Sep 08 05:29 PM
Szyman Catherine M.	CVP, Critical Care	Sep 08 '23	Sale	76.00	5,000	380,000	34,814	Sep 08 05:29 PM
Chopra Daveen	CVP, TMTT	Sep 06 '23	Option Exercise	59.26	8,500	503,682	32,450	Sep 06 05:09 PM
Chopra Daveen	CVP, TMTT	Sep 06 '23	Sale	76.07	8,500	646,609	23,950	Sep 06 05:09 PM
MUSSALLEM MICHAEL A	Director	Sep 05 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Sep 05 07:08 PM
MUSSALLEM MICHAEL A	Director	Sep 05 '23	Sale	75.86	29,350	2,226,491	4,486	Sep 05 07:08 PM
Ullem Scott B.	CVP, Chief Financial Officer	Aug 31 '23	Option Exercise	36.75	7,255	266,621	26,503	Aug 31 05:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	Aug 31 '23	Sale	77.79	7,255	564,366	19,248	Aug 31 05:34 PM
Chopra Daveen	CVP, TMTT	Aug 29 '23	Sale	76.69	1,500	115,040	23,950	Aug 29 05:31 PM
Wood Larry L	Global President TAVR & Surg	Aug 14 '23	Option Exercise	45.28	6,421	290,722	220,215	Aug 14 06:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '23	Option Exercise	36.75	4,500	165,375	44,003	Aug 14 06:02 PM
Wood Larry L	Global President TAVR & Surg	Aug 14 '23	Sale	79.30	6,421	509,185	213,794	Aug 14 06:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '23	Sale	79.30	4,500	356,850	39,503	Aug 14 06:02 PM
STONE HEISZ LESLIE	Director	Aug 10 '23	Sale	78.87	3,303	260,509	26,980	Aug 10 05:48 PM
Szyman Catherine M.	CVP, Critical Care	Aug 09 '23	Option Exercise	36.75	5,000	183,750	39,814	Aug 09 05:44 PM
Szyman Catherine M.	CVP, Critical Care	Aug 09 '23	Sale	78.64	5,000	393,185	34,814	Aug 09 05:44 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

PRCT

Procept BioRobotics Corp

EW

Edwards Lifesciences Corp

Upgrade your FINVIZ experience